Consistent with prior international studies, we observed that higher TNF-α, IL-6, and CRP levels correlate with advanced tumor stage and worse outcomes.14,15 These findings align with the understanding that chronic inflammation promotes immunosuppression and glioma progression. This evidence concerns the gene CRP and central nervous system cancer.